BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33442294)

  • 1. Clinical Response to Traditional Chinese Herbs Containing Realgar (As
    Zhou QB; Du Y; Zhang SS; Liu ZT; Ma R; Xu YG
    Cancer Manag Res; 2021; 13():55-63. PubMed ID: 33442294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arsenic Disulfide Promoted Hypomethylation by Increasing DNA Methyltransferases Expression in Myelodysplastic Syndrome.
    Zhou QB; Liu ZT; Wang HZ; Guo XQ; Xu YG; Hu XM
    Drug Des Devel Ther; 2020; 14():1641-1650. PubMed ID: 32431489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenic concentration in peripheral blood is correlated with efficacy of a Traditional Chinese Medicine regimen containing realgar for the treatment of myelodysplastic syndrome.
    Wang DX; Xu YG; Du Y; Wang HZ; Li L; Hu XM; Yang XP; Ma R; Zhou QB
    J Tradit Chin Med; 2021 Aug; 41(4):630-635. PubMed ID: 34392657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Traditional Chinese Medicine Containing Arsenic Treated MDS Patients Effectively through Regulating Aberrant Hypomethylation.
    Zhou QB; Zhu QZ; Wang HZ; Wang DX; Liu ZT; Xu YG; Hu XM; Ma R; Xu FQ
    Evid Based Complement Alternat Med; 2020; 2020():7469809. PubMed ID: 32215045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in the bone marrow histology between childhood myelodysplastic syndrome with multilineage dysplasia and refractory cytopenia of childhood without multilineage dysplasia.
    Iwafuchi H; Ito M
    Histopathology; 2019 Jan; 74(2):239-247. PubMed ID: 30062702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of arsenic disulfide on apoptosis, histone acetylation, toll like receptor 2 activation, and erythropoiesis in bone marrow mononuclear cells of myelodysplastic syndromes patients in vitro.
    Xu M; Ren JY; Guo YC; Xu BX; Zeng Q; Hu Q; Zhou YM; Lu JH
    Leuk Res; 2017 Nov; 62():4-11. PubMed ID: 28963909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Qinghuang Powder () Combined with Bupi Yishen Decoction () in Treating Patients with Refractory Cytopenia with Multilineage Dysplasia through Regulating DNA Methylation.
    Zhou QB; Yang XH; Wang HZ; Wang DX; Xu YG; Hu XM; Xu FQ; Ma R
    Chin J Integr Med; 2019 May; 25(5):354-359. PubMed ID: 29500545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of ASXL1 mutations in patients with myelodysplastic syndromes and multilineage dysplasia with or without ring sideroblasts.
    Mangaonkar AA; Gangat N; Al-Kali A; Elliott MA; Begna KH; Hanson CA; Ketterling RP; Wolanskyj-Spinner AP; Hogan WJ; Litzow MR; Patnaik MM
    Leuk Res; 2018 Aug; 71():60-62. PubMed ID: 30015104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene Expression and Methylation Pattern in HRK Apoptotic Gene in Myelodysplastic Syndrome.
    Zaker F; Amirizadeh N; Nasiri N; Razavi SM; Teimoori-Toolabi L; Yaghmaie M; Mehrasa R
    Int J Mol Cell Med; 2016; 5(2):90-9. PubMed ID: 27478805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic disulfide induced apoptosis and concurrently promoted erythroid differentiation in cytokine-dependent myelodysplastic syndrome-progressed leukemia cell line F-36p with complex karyotype including monosomy 7.
    Hu XM; Tanaka S; Onda K; Yuan B; Toyoda H; Ma R; Liu F; Hirano T
    Chin J Integr Med; 2014 May; 20(5):387-93. PubMed ID: 24610410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multilineage dysplasia (MLD) in acute myeloid leukemia (AML) correlates with MDS-related cytogenetic abnormalities and a prior history of MDS or MDS/MPN but has no independent prognostic relevance: a comparison of 408 cases classified as "AML not otherwise specified" (AML-NOS) or "AML with myelodysplasia-related changes" (AML-MRC).
    Miesner M; Haferlach C; Bacher U; Weiss T; Macijewski K; Kohlmann A; Klein HU; Dugas M; Kern W; Schnittger S; Haferlach T
    Blood; 2010 Oct; 116(15):2742-51. PubMed ID: 20581309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Realgar (α-As
    Zhang M; Zhang JY; Sun MQ; Lu P; Liu JX
    Chin J Integr Med; 2022 Mar; 28(3):281-288. PubMed ID: 32418175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of Mesenchymal Stromal Cells in Myelodysplastic Syndrome-with Multilineage Dysplasia (MDS-MLD).
    Abbas S; Kumar S; Srivastava VM; Therese M M; Nair SC; Abraham A; Mathews V; George B; Srivastava A
    Indian J Hematol Blood Transfus; 2019 Apr; 35(2):223-232. PubMed ID: 30988556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypomethylation of MIR-378 5'-flanking region predicts poor survival in young patients with myelodysplastic syndrome.
    Wu DH; Zhu XW; Wen XM; Zhang YY; Ma JC; Yao DM; Zhou JD; Guo H; Wu PF; Zhang XL; Qiu HC; Lin J; Qian J
    Mol Genet Genomic Med; 2020 Jan; 8(1):e1067. PubMed ID: 31833222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Karyotype and DNA-Methylation Responses in Myelodysplastic Syndromes following Treatment with Traditional Chinese Formula Containing Arsenic.
    Shuzhen S; Rou M; Xiaomei H; Xiao-Hong Y; Yong-Gang X; Hongzhi W; Xiu-Peng Y
    Evid Based Complement Alternat Med; 2012; 2012():969476. PubMed ID: 23118798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intragenic hypomethylation of DNMT3A in patients with myelodysplastic syndrome.
    Zhang YY; Zhou JD; Yang DQ; He PF; Yao DM; Qian Z; Yang J; Xu WR; Lin J; Qian J
    Clin Chem Lab Med; 2018 Feb; 56(3):485-491. PubMed ID: 29031013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related epigenetic drift in the pathogenesis of MDS and AML.
    Maegawa S; Gough SM; Watanabe-Okochi N; Lu Y; Zhang N; Castoro RJ; Estecio MR; Jelinek J; Liang S; Kitamura T; Aplan PD; Issa JP
    Genome Res; 2014 Apr; 24(4):580-91. PubMed ID: 24414704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-Genome DNA Methylation Sequencing Reveals Epigenetic Changes in Myelodysplastic Syndromes.
    Zhou JD; Xu ZJ; Jin Y; Zhang XL; Gu Y; Ma JC; Wen XM; Lin J; Zhang TJ; Qian J
    Front Oncol; 2022; 12():897898. PubMed ID: 35847864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide methylation sequencing identifies progression-related epigenetic drivers in myelodysplastic syndromes.
    Zhou JD; Zhang TJ; Xu ZJ; Deng ZQ; Gu Y; Ma JC; Wen XM; Leng JY; Lin J; Chen SN; Qian J
    Cell Death Dis; 2020 Nov; 11(11):997. PubMed ID: 33219204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant methylation of c-myc and c-fos protooncogenes and p53 tumor suppressor gene in myelodysplastic syndromes and acute non-lymphocytic leukemia.
    Papaggeli PC; Kortsaris AC; Matsouka PT
    J BUON; 2003; 8(4):341-50. PubMed ID: 17472275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.